Friday, November 22, 2013 3:47:05 PM
1) the price decline did not start for well over a week after that pure garbage was posted.
2) use of an Volume Weighted Average Price (VWAP) is dead typical for secondaries because it is a more accurate assessment of a company's true value. It protects both the buyers and seller from getting a bad deal due to very short term volatility AND from some scam newsletter jacking up or down the SP with a lot of shares right at the close to profit from either short or long positions (which is EXACTLY IMHO why this newsletter is so incensed about the use of the VWAP.
3) all the details of the warrants VWAP etc were fully known at the time of the secondary. Again the market would have reacted LONG ago if there was any substance whatsoever to this absurd claim!
4)filing a lawsuit (intending to quickly withdraw it once the trades have been made) is just a scumball tactic IMHO. NOTHING hidden was done. ALL of the details were fully public at all times.
5) The NAME of the newsletter says it all Terri BULL
The second link all I got was
"Not Acceptable!
An appropriate representation of the requested resource could not be found on this server. This error was generated by Mod_Security."
And I can't help but note that your ID was minted 20 minutes before your post which was the very first one you've done. Do you by any chance have any financial connection with "Teri Buhl"?
Which I find not at all surprising. (withdrawn because of a countersuit?)
This kind of flagrantly illegal manipulation is beyond disgusting.
IMHO a countersuit might well be successful (as it was with Overstocked.com)
2) use of an Volume Weighted Average Price (VWAP) is dead typical for secondaries because it is a more accurate assessment of a company's true value. It protects both the buyers and seller from getting a bad deal due to very short term volatility AND from some scam newsletter jacking up or down the SP with a lot of shares right at the close to profit from either short or long positions (which is EXACTLY IMHO why this newsletter is so incensed about the use of the VWAP.
3) all the details of the warrants VWAP etc were fully known at the time of the secondary. Again the market would have reacted LONG ago if there was any substance whatsoever to this absurd claim!
4)filing a lawsuit (intending to quickly withdraw it once the trades have been made) is just a scumball tactic IMHO. NOTHING hidden was done. ALL of the details were fully public at all times.
5) The NAME of the newsletter says it all Terri BULL
The second link all I got was
"Not Acceptable!
An appropriate representation of the requested resource could not be found on this server. This error was generated by Mod_Security."
And I can't help but note that your ID was minted 20 minutes before your post which was the very first one you've done. Do you by any chance have any financial connection with "Teri Buhl"?
Which I find not at all surprising. (withdrawn because of a countersuit?)
This kind of flagrantly illegal manipulation is beyond disgusting.
IMHO a countersuit might well be successful (as it was with Overstocked.com)
Recent NNVC News
- In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides • ACCESS Newswire • 05/26/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 10:01:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:30:33 PM
- NanoViricides Announces Closing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/19/2026 03:55:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/18/2026 12:45:22 PM
- Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides • ACCESS Newswire • 05/18/2026 12:30:00 PM
- NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/15/2026 12:35:00 PM
- NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II • ACCESS Newswire • 05/15/2026 12:00:00 PM
- Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides • ACCESS Newswire • 05/11/2026 12:30:00 PM
- NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference • Newsfile • 05/06/2026 07:37:00 PM
- NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA • ACCESS Newswire • 05/04/2026 12:30:00 PM
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
